Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Microdissection (ie, sample preparation of microscopically identified target); laser capture

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

Microdissection is a specialized technique used to isolate specific cells from a tissue sample for further analysis. In the context of CPT® Code 88380, this procedure employs laser capture microdissection, which allows for precise targeting of cells that have been microscopically identified as relevant for study. The process begins with the preparation of a thin section of tissue, which is then placed under a microscope. A transfer film is applied to this section, enabling the pathologist to visualize and select tiny clusters of cells that are of interest. Once the target cells are identified, a pulsed laser beam is directed at the transfer film, which fuses with the selected cells. This fusion allows for the removal of the cells from the tissue section, facilitating their analysis. The ability to isolate specific cells is crucial for studying disease processes at a cellular level, as it enables comparisons between abnormal or neoplastic cells and normal tissue. This information can be vital in determining appropriate treatment options for patients. In contrast, CPT® Code 88381 describes a manual method of microdissection, where selected cells are separated using traditional tools like a razor blade or scalpel under a dissecting microscope.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

Microdissection using laser capture is indicated for various clinical scenarios where precise cellular analysis is required. The following conditions may warrant the use of this procedure:

  • Targeted Cell Analysis This procedure is performed to isolate specific cells from a tissue sample that may exhibit abnormal or neoplastic characteristics, allowing for detailed examination and comparison with normal cells.
  • Research Purposes It is often utilized in research settings to study the cellular composition of tumors or other pathological tissues, aiding in the understanding of disease mechanisms.
  • Diagnostic Evaluation The technique is indicated for diagnostic purposes, particularly in cases where traditional methods may not provide sufficient information about the cellular makeup of a tissue sample.

2. Procedure

The procedure for laser capture microdissection (CPT® Code 88380) involves several critical steps to ensure accurate isolation of target cells. The following outlines the procedural steps:

  • Step 1: Tissue Preparation The first step involves preparing a thin section of the tissue sample, which is typically done using a microtome. This thin section is crucial for allowing clear visualization of the cells under a microscope.
  • Step 2: Application of Transfer Film Once the tissue section is prepared, a transfer film is placed over the section. This film is designed to adhere to the cells that will be targeted for isolation.
  • Step 3: Microscopic Visualization The tissue section, now covered with the transfer film, is examined under a microscope. The pathologist identifies and selects specific clusters of cells that are of interest for further study.
  • Step 4: Laser Activation After selecting the target cells, a pulsed laser beam is directed at the transfer film. This laser activates the film, causing it to fuse with the selected cells beneath it.
  • Step 5: Cell Removal The fused transfer film, now containing the selected cells, is carefully removed from the tissue section. This step allows for the isolation of the target cells for subsequent analysis.

3. Post-Procedure

After the laser capture microdissection procedure is completed, the isolated cells can be subjected to various analyses, including histological examination, molecular testing, or genetic profiling. The pathologist may need to document the specific cells that were isolated and the rationale for their selection. Additionally, care should be taken to ensure that the remaining tissue is preserved for any further necessary evaluations. The expected recovery from this procedure is typically minimal, as it is performed on a microscopic level and does not involve significant trauma to the surrounding tissue. However, the pathologist should monitor for any potential complications related to the handling of the tissue samples.

Short Descr MICRODISSECTION LASER
Medium Descr MICRODISSECTION PREP IDENTIFIED TARGET LASER
Long Descr Microdissection (ie, sample preparation of microscopically identified target); laser capture
Status Code Active Code
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 1 - Diagnostic Tests for Radiology Services
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Items and Services Packaged into APC Rates
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 234 - Pathology
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
TC Technical component; under certain circumstances, a charge may be made for the technical component alone; under those circumstances the technical component charge is identified by adding modifier 'tc' to the usual procedure number; technical component charges are institutional charges and not billed separately by physicians; however, portable x-ray suppliers only bill for technical component and should utilize modifier tc; the charge data from portable x-ray suppliers will then be used to build customary and prevailing profiles
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
AQ Physician providing a service in an unlisted health professional shortage area (hpsa)
GC This service has been performed in part by a resident under the direction of a teaching physician
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
Date
Action
Notes
2011-01-01 Changed Short description changed.
2008-01-01 Changed Code description changed.
2002-01-01 Added First appearance in code book in 2002.
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"